Home
>
Share Price
>
Pharmaceuticals
>
Glenmark Pharmaceuticals Ltd

Business
Price info
Price chart
Historical ratio
Margin & trade info
Quick overview
Review
Valuation analysis
Financial performance
Shareholding pattern
Historical price data
Latest news
Mutual fund holdings and trends
Similar stock

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK
BSE: 532296
ISIN: INE935A01035

₹766.45

+4.20 (0.55%)

Updated on: 27-09-2023 10:06 AM

NSE

BSE

Today’s Market Action
The last traded share price of Glenmark Pharmaceuticals Ltd was 766.45 up by 0.55% on the NSE. Its last traded stock price on BSE was 766.30 up by 0.49%. The total volume of shares on NSE and BSE combined was 306,707 shares. Its total combined turnover was Rs 23.52 crores.

Medium and Long Term Market Action
Glenmark Pharmaceuticals Ltd hit a 52-week high of 880 on 21-09-2023 and a 52-week low of 363.65 on 27-09-2022. The stock price of Glenmark Pharmaceuticals Ltd is down by 0% over the last one month. It is up by 108.27% over the last one year. Don’t forget to check the full stock price history in the table below.

About Glenmark Pharmaceuticals Ltd

Data not available.

Price info of Glenmark Pharmaceuticals Ltd

Day’s open
₹760.1
Previous close
₹762.25
VWAP
₹766.76
Lower price band
₹686.05
Upper price band
₹838.45

₹ 766.45

Day’s Low ₹760

Day’s High ₹770.3

₹ 766.45

52-w low ₹363.65(27-09-2022)

52-w high ₹880 (21-09-2023)

Glenmark Pharmaceuticals Ltd Price Chart

Historical Ratios Table & Returns of Glenmark Pharmaceuticals Ltd

Consolidated
Standalone

Margin & Trade Information of Glenmark Pharmaceuticals Ltd

Traded Volume
292,556 (Shares)
Traded Value
₹ 224,320,241.42

VAR Margin	\|	ELM Margin	\|	Adhoc	\|	Total Margin
13.06	+	3.50	+	0.00	=	16.56

Updated on: 27-09-2023 1:30 AM

Quick Overview of Glenmark Pharmaceuticals Ltd

Market Cap (Cr): 10509	Face Value (₹):	EPS (₹):
Book Value (₹):	Roce (%):	Debt to Equity:
Stock P/E:	ROE (%):	Dividend Yield (%): %
Revenue (Cr):	Earnings (Cr):	Cash (Cr):
Total Debt (Cr):	Promoter’s Holdings (%):

Review of Glenmark Pharmaceuticals Ltd

Pros

Cons

Valuation Analysis of Glenmark Pharmaceuticals Ltd

Margin of safety
(27/09/2023)

Stock Valuation

Margin of Safety Index:

76.92%

76.92% People are bullish about Glenmark Pharmaceuticals Ltd

23.08%

23.08 % People are bearish about Glenmark Pharmaceuticals Ltd

What is your opinion about this Stock?

Financial Performance of Glenmark Pharmaceuticals Ltd
(Figures in Rs. Crores)

Quarterly results
Profit loss
Balance sheet
Cash flow statement

Quarterly results
Profit loss
Cash flow statement

Consolidated
Standalone

Consolidated
Standalone

Consolidated
Standalone

Consolidated
Standalone

Shareholding Pattern (%) of Glenmark Pharmaceuticals Ltd

	JUN 2020	SEP 2020	DEC 2020	MAR 2021	JUN 2021	SEP 2021	DEC 2021	MAR 2022	JUN 2022
Promoters	46.62	46.63	46.63	46.63	46.63	46.65	46.65	46.65	46.65
FIIs	23.4	25.79	26.48	25.84	26.82	25.93	24.18	24.12	24.23
DIIs	5.53	4.46	9.43	9.16	9.73	9.03	10.86	10.96	10.5
Government	0	0	0	0	0	0	0	0	0
Public	24.44	23.13	17.46	18.38	16.82	18.4	18.31	18.27	18.63
Others	0	0	0	0	0	0	0	0	0

Historical Price Data of Glenmark Pharmaceuticals Ltd

From

To

Last 30 Days
Last 90 Days
Last 180 Days
Last 365 Days
Last FY
Current FY
Life Time

Date	Open	High	Low	Close	Volume	Daily Change %

Latest News About Glenmark Pharmaceuticals Ltd

Mutual fund holdings and trends of Glenmark Pharmaceuticals Ltd

Schemes	Quantity	As on	Prev. Qty	Change (Qty)	Trend

Similar stocks to Glenmark Pharmaceuticals Ltd

Company

Price

Market Cap (Cr)

P/E

Order Type

Buy
Sell

CMP

₹ 766.45

+4.20 (0.55%)

Quantity

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings
with Samco

()

Sign up for a Samco account and save upto 98% of your brokerage cost

Sign up for free

Stamp duty calculated based on state of Maharashtra